Aspects of the immunologic treatment of lung cancer.
D000230:Adenocarcinoma / Q000276:immunology; D002277:Carcinoma / Q000276:immunology; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D010447:Peptide Hydrolases / Q000627:therapeutic use; D011379:Prognosis; D013997:Time Factors
D010447:Peptide Hydrolases